Attached files

file filename
10-K - 10-K - Rasna Therapeutics Inc.rasp-20190930.htm
EX-32.2 - EXHIBIT 32.2 - Rasna Therapeutics Inc.ex322_6.htm
EX-32.1 - EXHIBIT 32.1 - Rasna Therapeutics Inc.ex321_5.htm
EX-31.2 - EXHIBIT 31.2 - Rasna Therapeutics Inc.ex312_4.htm
EX-31.1 - EXHIBIT 31.1 - Rasna Therapeutics Inc.ex311_3.htm
EX-21 - EXHIBIT 21 - Rasna Therapeutics Inc.ex21_1.htm
Exhibit 24

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints, jointly and severally, Kunwar Shailubhai, his attorney-in-fact, each with full power of substitution and resubstitution, for him in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Signature
  
Title(s)
  
Date
 
 
 
 
 
 /s/ Kunwar Shailubhai
  
 
  
 
Kunwar Shailubhai
  
Director,  Chief Executive Officer
  
January 13, 2020
  
  
(Principal Executive Officer)
  
 
/s/ Tiziano Lazzaretti
 
 
 
 
Tiziano Lazzaretti
  
Chief Financial Officer
  
January 13, 2020
 
  
(Principal Accounting and Financial Officer)
  
 
 /s/ John Brancaccio
  
 
  
 
John Brancaccio
  
Director
  
January 13, 2020
 
 
 
 
 
 /s/ Alessandro Padova
  
 
  
 
Alessandro Padova
   Director

January 13, 2020